Therefore, hMSC-EC secretome, particularly a cocktail of angiopoietin-1 and 2, FGF-7, MMP-9, and VEGF-C, are potential new therapeutic targets for improving wound-healing in diabetes. Here, FGF7 is linked to diabetes mellitus.